Data dive finds cheap diuretic could be Alzheimer’s drug
pharmaphorum
OCTOBER 12, 2021
The research has focused on Alzheimer’s associated with an apolipoprotein E4 (APOE4) gene variant known to be a major risk factor for late-onset forms of the disease. All told, five drugs emerged with a gene expression signature that the researchers believed might help neutralise the disease, but the strongest candidate was bumetanide.
Let's personalize your content